Kevin Schulman

Professor (by courtesy), Operations, Information & Technology

Kevin Schulman

Professor of Operations, Information & Technology (by courtesy)

Professor of Medicine and Professor of Health Policy (by courtesy), School of Medicine


Dr. Schulman was appointed as Professor of Medicine, Associate Chair of Business Development and Strategy in the Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center (CERC) and the Director of the Master of Science in Clinical Informatics Management program at the Stanford University School of Medicine. He was also appointed, by courtesy, Professor of Economics at Stanford’s Graduate School of Business (GSB) in June 2018; and, by courtesy, Professor of Operations, Information and Technology at Stanford’s GSB in June 2021.

Dr. Schulman’s research interests include organizational innovation in health care, health care policy and health economics.  With over 300 original articles, over 100 review articles/commentaries, and over 40 case studies/book chapters, Kevin Schulman has had a broad impact on health policy (h-index = 77). His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Health Policy, Management and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Services Research.

Prior to coming to Stanford, Dr. Schulman served as a Professor of Medicine at Duke University, directed the Health Sector Management Program at Duke’s Fuqua School of Business for a dozen years, created and directed the Duke University Master of Management in Clinical Informatics Program, and served as a Visiting Professor and Visiting Scholar at Harvard Business School.

He is an elected member of ASCI and AAP. He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program.


Journal Articles

Chen Wei, Ishan Paranjpe, Pranav Sharma, Michael Milligan, Miranda Lam, Paul A. Heidenreich, Neil Kalwani, Kevin Schulman, Alexander Sandhu
Journal of the American Heart Association
February 2024 Vol. 13 Issue 4
Ashwin Nayak, Sharif Vakili, Kristen Nayak, Margaret Nikolov, Michelle Chiu, Philip Sosseinheimer, Sarah Talamantes, Stefano Testa, Srikanth Palanisamy, Vinay Giri, Kevin Schulman
JAMA Network Open
December 2023 Vol. 6 Issue 12
Kristina Gligorić, Chaitanya Kamath, Daniel J. Weiss, Shailesh Bavadekar, Yun Liu, Tomer Shekel, Kevin Schulman, Evgeniy Gabrilovich
Communications Medicine
November 2023 Vol. 3 Issue 1
Zachary A. Sexton, Juliana R. Perl, Henry R. Saul, Artem A. Trotsyuk, Jan B. Pietzsch, Sandra Waugh Ruggles, Margaret C. Nikolov, Kevin Schulman, Joshua Makower
JAMA Health Forum
August 2023 Vol. 4 Issue 8
Daniel S. Bowling, Barak D. Richman, Kevin Schulman
Health Services Research
December 2022 Vol. 57 Issue 6 Pages 1214–1217
Paul Dupenloup, Ryan Leonard Pei, Annie Chang, Michael Z. Gao, Priya Prahalad, Ramesh Johari, Kevin Schulman, Ananta Addala, Dessi Zaharieva, David M. Maahs, David Scheinker
Frontiers in Endocrinology
November 2022
Wasan Kumar, Kevin Schulman
American Journal of Medicine
October 2022
Mayuri Chandran, Kevin Schulman
Health Services Research
April 2022 Vol. 57 Issue 2 Pages 218–222
Ben Teasdale, Amanda Nguyen, Jeroen van Meijgaard, Kevin Schulman
Health Services Research
February 25, 2022
Barak D. Richman, Robert S. Kaplan, Japees Kohli, Dennis Purcell, Mahek Shah, Igna Bonfrer, Brian Golden, Rosemary Hannam, Will Mitchell, Daniel Cehic, Garry Crispin, Kevin Schulman
Health Affairs
2022 Vol. 41 Issue 8 Pages 1098–1106
Neil Gandhi, Kevin Schulman
Health Affairs (Millwood)
December 2021 Vol. 40 Issue 12 Pages 1926–1934
Barak Richman, Mark Hall, Kevin Schulman
The New England Journal of Medicine
October 7, 2021 Vol. 385 Pages 1348–1351
David Scheinker, Barak D. Richman, Arnold Milstein, Kevin Schulman
Health Services Research
March 31, 2021
Stacy Wood, Kevin Schulman
The New England Journal of Medicine
February 18, 2021 Vol. 384 Issue 7 Pages E231–E238
A. Jay Holmgren, N. Lance Downing, David W. Bates, Tait D. Shanafelt, Arnold Milstein, Christopher D. Sharp, David M. Cutler, Robert S. Huckman, Kevin Schulman
JAMA Internal Medicine
February 2021 Vol. 181 Issue 2 Pages 251–259

Stanford Case Studies

Kevin Schulman, Noel Ayoub, Frank Lin
Kevin Schulman, James Tai, Ethan Goh, Margaret Wenzlau, Shikha Avancha
Kevin Schulman, Megan Eluhu
Kevin Schulman, Aditya Narayan
Kevin Schulman, Morgan Kiss
Kevin Schulman, Abishek Thiagaraj
Kevin Schulman, Justus Kilonzi, John Muthee
Kevin Schulman, Summer Hu, Jiayin Xue, Susan Qi
Kevin Schulman, Adesh Surendra Jain, Pieter Naude Bremer Du Plessis
Kevin Schulman, Natalie Yu
Cindie Wu Gaspar, Kevin Schulman, David Scheinker
Kevin A. Schulman, Kevin Ho
Kevin Schulman, Stacy Wood

Insights by Stanford Business

November 01, 2022
$215 to process a routine medical procedure? It’s not like this everywhere.
February 23, 2022
Two doctors propose federal subsidies to accelerate R&D on urgently needed antibiotics.